Work for Rhythm Pharmaceuticals, Inc.?

Claim Your Profile

Rhythm Pharmaceuticals, Inc. Logo Image

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. Banner Image

About Rhythm Pharmaceuticals, Inc.

51-200 Employees
Based in Boston, Massachusetts

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm’s lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).

Ticker:
RYTM
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol